Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ... Aug 31
Biocon Biologics receives EU GMP certification for multiple biosimilars manufacturing facilities in Bengaluru ... May 27
-Advertisements-